CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products

CJ食品和T＆R Biofab旨在协同其独特的专业知识和技术，将创新食品推向市场

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agreement (JDA) with T&R Biofab to develop alternative meat using 3D bioprinting technology. T&R Biofab is a med-tech company that develops artificial tissues using its world-class technology in the field of regenerative medicine based on 3D bioprinting..

韩国首尔，2023年10月18日/PRNewswire/-韩国CJ CheilJedang业务部门CJ Foods宣布与T＆R Biofab签订联合开发协议（JDA），以开发替代品肉类使用3D生物打印技术。T＆R Biofab是一家med-tech公司，利用其基于3D生物打印的再生医学领域的世界级技术开发人造组织。。

Through this collaboration, the two innovative Korean companies will leverage synergies between the food industry and the 3D printing medical field to elevate new plant-based alternative protein products up to consumers' expectations on taste, texture, appearance, and nutrition. Plant-based alternative protein food products beyond the limitations of today's offerings are seen as new growth engines for both companies..

通过这项合作，两家创新的韩国公司将利用食品工业和3D打印医疗领域之间的协同作用，提升新的基于植物的替代蛋白质产品，使其达到消费者对味道，质地，外观和营养的期望。基于植物的替代蛋白质食品超越了当今产品的限制，被视为两家公司的新增长引擎。。

According to Bloomberg Intelligence, the plant-based food market is estimated to be worth USD 162 billion by 2030, showing a rapid growth from USD 24.9 billion in 2020. Plant-based food has emerged as a major trend, extending beyond concerns about animal welfare to be recognized for its positive impact on health, nutrition, and environmental.

根据彭博情报，到2030年，植物性食品市场估计价值1620亿美元，从2020年的249亿美元快速增长。植物性食品已成为一种主要趋势，超越了对动物福利的担忧，因为它对健康，营养和环境产生积极影响。

Nevertheless, one challenge has persisted – achieving the authentic texture and mouthfeel of animal-based food..

然而，仍然存在一个挑战-实现动物性食品的真实质地和口感。。

'At CJ Foods, we recognize that breakthrough innovation happens at the interface of distinctly different proficiencies and industries,' stated Dr. Florian Viton, Senior Vice President, Strategic Innovation at CJ Foods. 'We see our partnership with T&R Biofab as a unique opportunity to create alternative protein offerings that truly surpass the limitations hindering today's plant-based products.

“在CJ Foods，我们认识到突破性创新发生在截然不同的盈利和行业界面上，”CJ Foods战略创新高级副总裁Florian Viton博士说我们将与T＆R Biofab的合作关系视为创建替代蛋白质产品的独特机会，这些产品真正超越了阻碍当今植物产品的限制。

This exciting collaboration is part of CJ Food's broader strategy to accelerate our pace of innovation and seed new growth engines in support of CJ Food's global ambitions.'.

这一激动人心的合作是CJ食品更广泛战略的一部分，以加快我们的创新步伐，并种植新的增长引擎，以支持CJ食品的全球雄心壮志。

'As global leaders and public figures increasingly draw attention to the alternative protein food sector, particularly the potential within 3D printed food, it is imperative to underscore that this domain seldom unites genuine food industry experts with accomplished printing specialists,' commented Dr.

“随着全球领导者和公众人士越来越关注替代蛋白质食品行业，特别是3D打印食品的潜力，必须强调的是，这一领域很少将真正的食品行业专家与经验丰富的印刷专家联系起来，”Dr。

Paulo Marinho, Head of Scientific Strategy of T&R Biofab. 'This partnership stands as a unique instance where these two domains converge and collaborate, each pioneering its own sphere to achieve a shared and essential solution.'.

T＆R Biofab科学战略负责人Paulo Marinho这种伙伴关系是这两个领域融合和协作的独特实例，每个领域都开创了自己的领域，以实现共享和基本的解决方案。

CJ Foods remains committed to developing and investing technologies aimed at securing sustainable food for the future. Notably, it launched a brand specializing in plant-based foods and offers plant-based Mandu products in both overseas and Korean markets. In addition, last year, CJ Foods introduced a plant-based beverage brand, Altive, through its in-house food venture program known as INNO 100..

CJ食品仍然致力于开发和投资旨在确保未来可持续食品的技术。值得注意的是，它推出了一个专门从事植物性食品的品牌，并在海外和韩国市场提供植物性柑橘产品。此外，去年，CJ Foods通过其名为INNO 100的内部食品风险计划推出了一个以植物为基础的饮料品牌Altive。。

About CJ FoodsCJ Foods, a business unit of CJ CheilJedang, is a global food company delivering a variety of products ranging from foodstuffs and frozen/chilled foods to appetizers. As the largest food company in Korea with global sales of 11.1 trillion KRW in 2022, CJ Foods is now leading the globalization of Korean food with its fast-growing bibigo brand.

关于CJ FoodsCJ Foods，CJ CheilJedang的一个业务部门，是一家全球食品公司，提供从食品，冷冻/冷冻食品到开胃菜的各种产品。作为2022年全球销售额为11.1万亿韩元的韩国最大的食品公司，CJ食品现在以其快速增长的bibigo品牌引领韩国食品全球化。

Under bibigo, CJ currently focuses on seven delicious Global Strategic Products of K-food, including Mandu (Korean-style dumpling), chicken, processed rice, Korean sauce, Kimchi, Gim (seaweed), and roll to global consumers. The company operates over 60 sites in multiple regions worldwide including South Korea, the U.S.

在比比戈（bibigo）的领导下，CJ目前专注于K食品的七种美味全球战略产品，包括Mandu（韩式垃圾），鸡肉，加工大米，酱油，泡菜，Gim（海藻）以及向全球消费者推广。该公司在全球多个地区运营超过60个站点，包括韩国，美国。

(Schwan's Company), China, Japan, Southeast Asia, Europe, and Oceania..

（施万公司），中国，日本，东南亚，欧洲和大洋洲。。

For more information, visit https://www.cj.co.kr/en/about/business/food

有关更多信息，请访问https://www.cj.co.kr/en/about/business/food

About CJ CheilJedangCJ CheilJedang is a South Korea-based food & bio company operating globally. Founded in 1953 as the first Korean sugar manufacturer, it is now a leading global food player with brands such as bibigo. It also provides advanced bio products including feed and food additives made by its cutting-edge, fermentation-based bioengineering technologies.

关于CJ CheilJedangCJ CheilJedang是一家在全球运营的韩国食品和生物公司。它成立于1953年，是第一家韩国糖业制造商，现在是bibigo等品牌的全球领先食品企业。它还提供先进的生物产品，包括由其尖端的基于发酵的生物工程技术制造的饲料和食品添加剂。

The company recorded sales of 30 trillion KRW in 2022. CJ CheilJedang is part of CJ Group, an international company in the fields of Food & Food Services, Bio & Pharma, Entertainment & Media, and Retail & Logistics..

该公司在2022年的销售额为30万亿韩元。CJ CheilJedang是CJ Group的一部分，CJ Group是食品与食品服务，生物与制药，娱乐与媒体以及零售与物流领域的国际公司。。

For more information, visit https://www.cj.co.kr/en

有关更多信息，请访问https://www.cj.co.kr/en

About T&R BiofabT&R Biofab is a science-driven and fast-growing company which has developed its own 3D Bio-printing System and its own Proprietary Biomaterials for the creation of Implantable Medical Devices, Bio-surgical Solutions, 3D Organoid Models, and Artificial Organs. At its origin, T&R Biofab started its business with the development and commercialization of 3D Bio-printing equipment.

关于T＆R BiofabT＆R Biofab是一家科学驱动和快速发展的公司，已经开发出自己的3D生物打印系统和自己专有的生物材料，用于创建植入式医疗设备，生物外科解决方案，3D类器官模型和人造器官。T＆R Biofab起源于3D生物打印设备的开发和商业化。

Quickly, T&R recognized that there were unmet needs on the medical field where Bioprinting could offer a unique solution, however, to translate that science to products that would benefit society, the use of other cutting-edge technologies such as biomimetic biomaterials and stem cells were needed, and the company quickly expanded its R&D capabilities.

很快，T＆R认识到医疗领域的需求尚未得到满足，生物打印可以提供独特的解决方案，然而，为了将该科学转化为有益于社会的产品，使用其他尖端技术，如仿生生物材料和干细胞。需要，公司迅速扩大其研发能力。

After securing key IP, filing over 150 patents, and writing more than 200 SCI articles; T&R owns the core technology to address the most challenging problems in healthcare. Adding to this unique set of expertise, the longstanding collaborations with the biggest MedTech in the world, prepared T&R Biofab to what is necessary to achieve a globally successful product; therefore, delivering solutions that are not only needed but also reliable and impact-lasting..

获得关键知识产权，提交150多项专利，撰写200多篇SCI文章；T＆R拥有核心技术来解决医疗保健中最具挑战性的问题。除了这套独特的专业知识之外，与世界上最大的MedTech长期合作，为实现全球成功产品所必需的T＆R Biofab做好了准备；因此，提供不仅需要而且可靠且持久的解决方案。。

For more information, visit http://tnrbiofab.com/

For more information, visit http://tnrbiofab.com/

SOURCE CJ CheilJedang

来源CJ CheilJedang